NovaDigm Therapeutics Announces Initiation of Phase 2a Clinical Trial of NDV-3A in Staphylococcus aureus Read more
PhoenixMD Announces Manufacturing Collaboration with WuXi STA to advance PMD-026 toward IND Read more
FDA grants Breakthrough Therapy Designation for Roche’s Hemlibra in haemophilia A without inhibitors Read more
Sandoz and Pear Therapeutics to develop and commercialize prescription digital therapeutics Read more